SG11201610413RA - Lactic acid bacteria suppressing purine absorption and use thereof - Google Patents
Lactic acid bacteria suppressing purine absorption and use thereofInfo
- Publication number
- SG11201610413RA SG11201610413RA SG11201610413RA SG11201610413RA SG11201610413RA SG 11201610413R A SG11201610413R A SG 11201610413RA SG 11201610413R A SG11201610413R A SG 11201610413RA SG 11201610413R A SG11201610413R A SG 11201610413RA SG 11201610413R A SG11201610413R A SG 11201610413RA
- Authority
- SG
- Singapore
- Prior art keywords
- lactic acid
- acid bacteria
- purine absorption
- bacteria suppressing
- suppressing purine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
- C12P19/28—N-glycosides
- C12P19/30—Nucleotides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Mycology (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014134973 | 2014-06-30 | ||
| JP2014234050 | 2014-11-18 | ||
| JP2015064201 | 2015-03-26 | ||
| PCT/JP2015/068785 WO2016002757A1 (en) | 2014-06-30 | 2015-06-30 | Lactic acid bacterium for suppressing purine absorption and use for same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201610413RA true SG11201610413RA (en) | 2017-02-27 |
Family
ID=55019289
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201610413RA SG11201610413RA (en) | 2014-06-30 | 2015-06-30 | Lactic acid bacteria suppressing purine absorption and use thereof |
Country Status (4)
| Country | Link |
|---|---|
| JP (1) | JP6637419B2 (en) |
| CN (1) | CN106460029A (en) |
| SG (1) | SG11201610413RA (en) |
| WO (1) | WO2016002757A1 (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108703218A (en) * | 2018-05-24 | 2018-10-26 | 南京小洋人生物科技发展有限公司 | A kind of preparation method for the fermented type sour milk beverage for inhibiting purine to absorb |
| CA3103356A1 (en) * | 2018-07-24 | 2020-01-30 | Biogaia Ab | Therapeutic methods using bacterial strains which are capable of increasing adenosine levels |
| MX2020012770A (en) | 2018-07-24 | 2021-02-15 | Biogaia Ab | Selection and use of melatonin supporting bacteria to reduce infantile colic. |
| TWI719691B (en) * | 2019-10-28 | 2021-02-21 | 葡萄王生技股份有限公司 | Use of lactobacillus reuteri gkr1 for preparing composition of reducing uric acid |
| CN110747146B (en) * | 2019-11-28 | 2022-05-27 | 微康益生菌(苏州)股份有限公司 | Lactobacillus gasseri LG08 with uric acid degradation effect and application thereof |
| CN115725437B (en) * | 2022-07-20 | 2024-04-30 | 江南大学 | Lactobacillus mucilaginosus capable of efficiently utilizing purine and application thereof in yellow wine brewing |
| CN115478028B (en) * | 2022-09-13 | 2023-12-15 | 南昌大学 | Lactobacillus acidophilus F02, preparation prepared from lactobacillus acidophilus F02 and application of lactobacillus acidophilus F02 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3013157B2 (en) * | 1996-09-27 | 2000-02-28 | カルピス株式会社 | Lactic acid bacteria fermented milk material with suppressed increase in lactic acidity |
| KR20060028426A (en) * | 2003-06-24 | 2006-03-29 | 오츠카 세이야쿠 가부시키가이샤 | Composition for lowering serum uric acid level |
| JP5237581B2 (en) * | 2006-05-31 | 2013-07-17 | 株式会社明治 | Lactic acid bacteria with action to reduce blood uric acid level |
| JP5044643B2 (en) * | 2007-03-20 | 2012-10-10 | 三和酒類株式会社 | Serum uric acid level-lowering agent and food / beverage products with a label to reduce serum uric acid level |
| CA2718157C (en) * | 2007-11-29 | 2018-08-21 | Meiji Dairies Corporation | Lactobacillus gasseri capable of lowering blood uric acid level |
| EP2457576B1 (en) * | 2010-11-29 | 2020-07-08 | Eurochit Danuta Kruszewska | Lactobacillus reuteri strain for use in the medical and veterinary prophylaxis and treatment of metabolic syndrome or infections |
-
2015
- 2015-06-30 SG SG11201610413RA patent/SG11201610413RA/en unknown
- 2015-06-30 WO PCT/JP2015/068785 patent/WO2016002757A1/en active Application Filing
- 2015-06-30 JP JP2016531383A patent/JP6637419B2/en active Active
- 2015-06-30 CN CN201580030523.3A patent/CN106460029A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN106460029A (en) | 2017-02-22 |
| JPWO2016002757A1 (en) | 2017-04-27 |
| JP6637419B2 (en) | 2020-01-29 |
| WO2016002757A1 (en) | 2016-01-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL252135B (en) | Triazolopyrimidine compounds and uses thereof | |
| IL247072A0 (en) | Medical use | |
| GB201403093D0 (en) | Therapeutic compounds and their use | |
| HK1245641A1 (en) | Hypochlorous acid formulations and methods for treating skin conditions | |
| GB201401617D0 (en) | Novel combination and use | |
| GB2529728B (en) | Shaped or textured medical balloon with strengthening elements | |
| SG11201610413RA (en) | Lactic acid bacteria suppressing purine absorption and use thereof | |
| IL283335B (en) | Dihydropyrimidin-2-one compounds and medical use thereof | |
| GB201511382D0 (en) | Novel compounds and their use in therapy | |
| SG11201608217PA (en) | Fatty acid composition and use thereof | |
| ZA201701312B (en) | Novel imidazopyridazine compounds and their use | |
| SG11201607600TA (en) | Vaginal composition and use thereof | |
| HK1232145A1 (en) | Bifunctional compounds and use for reducing uric acid levels | |
| HK1243077A1 (en) | Piperidinylpyrazolopyrimidinones and their use | |
| SG11201702816QA (en) | Lactic acid bacteria having purine uptake ability and use thereof | |
| IL251840A0 (en) | Use of pemirolast in the treatment of acute asthma | |
| GB201404265D0 (en) | Respiratory analysis and treatment | |
| GB201409978D0 (en) | Novel compounds and their use in therapy | |
| SG11201704019TA (en) | 6-aryl-9-glycosylpurines and use thereof | |
| ZA201408464B (en) | Composition for the use in treatment of asthma | |
| GB201419175D0 (en) | Compounds with activity against bacteria and mycobacteria | |
| GB201410387D0 (en) | Compounds and their therapeutic use | |
| GB201413411D0 (en) | Novel compounds and their use | |
| GB201403496D0 (en) | Compounds and their therapeutic use |